{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:44:45Z","timestamp":1766767485314,"version":"3.40.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yantai city key research and development projects","award":["2018XDHZ101"],"award-info":[{"award-number":["2018XDHZ101"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Myasthenia gravis is a common autoimmune disease in clinic. Although there are various ways and drugs for the treatment of myasthenia gravis in Western medicine, there are still a variety of adverse reactions. Studies have shown that Buzhong Yiqi decoction combined with Western medicine has a certain efficacy in the treatment of myasthenia gravis, but there is a lack of evidence-based medicine. The research carried out in this scheme is to systematically evaluate the efficacy and safety of Buzhong Yiqi decoction combined with Western medicine in the treatment of myasthenia gravis, and to provide reliable evidence for guiding clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>English databases (the Cochrane Library, PubMed, Web of Science, Embase) and Chinese databases (China Biomedical Database, China Science and Technology Journal Database, China National Knowledge Infrastructure, Wanfang) will be searched by computer. In addition, Baidu Academic and Chinese Clinical Trial Registration Center will be searched manually. A randomized controlled clinical trial of Buzhong Yiqi decoction combined with Western medicine in the treatment of myasthenia gravis will be conducted from the establishment of the database to December 2020. The 2 researchers independently carry out data extraction and literature quality evaluation on the quality of the included study, and meta-analysis of the included literature will be carried out by using RevMan 5.3 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will evaluate the efficacy and safety of Buzhong Yiqi decoction combined with Western medicine in the treatment of myasthenia gravis by Quantitive MGscore, the number of Tregs cells and the content of anti-acetylcholine receptor antibody (AchR-Ab).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will provide reliable evidence-based evidence for the clinical application of Buzhong Yiqi decoction combined with Western medicine in the treatment of myasthenia gravis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval was not required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OSF Registration number:<\/jats:title>\n            <jats:p>DOI 10.17605\/OSF.IO\/MXUPK.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024807","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T22:08:31Z","timestamp":1615932511000},"page":"e24807","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of Buzhong Yiqi decoction combined with western medicine in the treatment of myasthenia gravis"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-7868","authenticated-orcid":false,"given":"Gang","family":"Zong","sequence":"first","affiliation":[{"name":"Jiaozhou Central Hospital of Qingdao, Jiaozhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiliang","family":"Liu","sequence":"additional","affiliation":[{"name":"Community Health Service Center, Qingdao, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunling","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiaozhou Central Hospital of Qingdao, Jiaozhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulei","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiaozhou Central Hospital of Qingdao, Jiaozhou"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"564579","DOI":"10.3389\/fmicb.2020.564579","article-title":"Differential gut microbiota and fecal metabolites related with the clinical subtypes of myasthenia gravis","volume":"11","author":"Tan","year":"2020","journal-title":"Front Microbiol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bjan.2020.05.004","article-title":"Perioperative challenges and neuromuscular blockade concerns in robotic thymectomy for myasthenia gravis","volume":"70","author":"Pal","year":"2020","journal-title":"Rev Bras Anestesiol"},{"key":"R3-20250504","first-page":"1","article-title":"Speech characteristics in individuals with myasthenia gravis: a case control study","author":"Ayres","year":"2020","journal-title":"Logoped Phoniatr Vocol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ncl.2020.09.007","article-title":"Update in the management of myasthenia gravis and lambert-eaton myasthenic syndrome","volume":"39","author":"Bodkin","year":"2021","journal-title":"Neurol Clin"},{"key":"R5-20250504","article-title":"Autoantibodies in Japanese patients with ocular myasthenia gravis","author":"Nagaishi","year":"2020","journal-title":"Muscle Nerve"},{"key":"R6-20250504","first-page":"106","article-title":"The duke myasthenia gravis clinic registry: I. description and demographics","volume":"33","author":"Sanders","year":"2020","journal-title":"Muscle Nerve"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"rjaa321","DOI":"10.1093\/jscr\/rjaa321","article-title":"Case series: a case of familial thymomatous myasthenia gravis in a family of three male brothers","volume":"2020","author":"Elseidy","year":"2020","journal-title":"J Surg Case Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12974-020-01958-3","article-title":"Decreased expression of miR-29 family associated with autoimmune myasthenia gravis","volume":"17","author":"Cron","year":"2020","journal-title":"J Neuroinflam"},{"key":"R9-20250504","first-page":"452","article-title":"Role of thymus on prognosis of myasthenia gravis in Turkish population","volume":"7","author":"Tireli","year":"2020","journal-title":"North Clin Istanb"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"30649","DOI":"10.1073\/pnas.2007206117","article-title":"Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis","volume":"117","author":"Jiang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-20250504","first-page":"102712","article-title":"Update in immunosuppressive therapy of myasthenia gravis","volume":"11","author":"Lascano","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R12-20250504","first-page":"407","article-title":"Research progress in the treatment of myasthenia gravis with traditional Chinese medicine","volume":"28","author":"Mingming","year":"2017","journal-title":"Med J Chin People's Armed Police Force"},{"key":"R13-20250504","first-page":"355","article-title":"Yang Guohan's experience in treating myasthenia gravis with Buzhong Yiqi decoction","volume":"35","author":"Shenxing","year":"2019","journal-title":"J Pract Tradit Chin Med"},{"key":"R14-20250504","first-page":"235","article-title":"Clinical observation of high-dose Buzhong Yiqi decoction combined with prednisone in the treatment of myasthenia gravis","volume":"25","author":"Wei","year":"2013","journal-title":"Clin J Tradit Chin Med"},{"issue":"(A4)","key":"R15-20250504","first-page":"143","article-title":"Effect of Buzhong Yiqi decoction on humoral immune function of peripheral blood in patients with myasthenia gravis","volume":"17","author":"Fuqiang","year":"2017","journal-title":"World Latest Med Inform"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/CH-170320","article-title":"Ecchymosis: a novel sign in patients with varicose veins","volume":"68","author":"Yetkin","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"R17-20250504","first-page":"100226","article-title":"Myasthenia gravis and large granular lymphocytic leukemia: a rare association","volume":"14","author":"Zhang","year":"2020","journal-title":"Leuk Res Rep"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12883-020-01975-y","article-title":"Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre","volume":"20","author":"Nedkova-Hristova","year":"2020","journal-title":"BMC Neurol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jocn.2020.06.023","article-title":"Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China","volume":"79","author":"Fan","year":"2020","journal-title":"J Clin Neurosci"},{"key":"R20-20250504","first-page":"193","article-title":"Magnetic resonance imaging characteristics of thymoma in Vietnamese patients with myasthenia gravis in relation to histopathological type and disease staging","volume":"24","author":"Tuan","year":"2020","journal-title":"Contemp Oncol (Pozn)"},{"key":"R21-20250504","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","author":"Uzawa","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"R22-20250504","first-page":"e10248","article-title":"Myasthenia gravis and its association with thyroid diseases","volume":"12","author":"Amin","year":"2020","journal-title":"Cureus"},{"key":"R23-20250504","first-page":"82","article-title":"Clinical research status of myasthenia gravis","volume":"33","author":"Lifang","year":"2016","journal-title":"J Apoplexy Nerv Dis"},{"key":"R24-20250504","first-page":"5011","article-title":"Changes of CD4 + T cell function in peripheral blood of patients with myasthenia gravis and its related mechanism","volume":"37","author":"Miao","year":"2017","journal-title":"Chin J Gerontol"},{"key":"R25-20250504","first-page":"3336","article-title":"Effects of Buzhong Yiqi decoction on treg lymphocyte, lymphocyte subsets and on the curative effects of elderly patients with myasthenia gravis","volume":"15","author":"Xinyan","year":"2020","journal-title":"World Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:29:00Z","timestamp":1746340140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024807"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024807","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"2021-01-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}